Abrams, P, Andersson, KE, Buccafusco, JJ, et al. (2006) Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. British Journal of Pharmacology, 148: 565–78.
Bell, TJ, Panchal, SJ, Miaskowski, C, et al. (2009) The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1). Pain Medicine, 10: 35–42.
Bickerstaff, LK, Harris, SC, Leggett, RS, et al. (1988) Pain insensitivity in schizophrenic patients: a surgical dilemma. The Archives of Surgery, 123: 49–51.
Byers, RJ, Marsh P, Parkinson D, et al. (1997) Melanosis coli is associated with an increase in colonic epithelial apoptosis and not with laxative use. Histopathology, 30: 160–4.
Chengappa, KN, Pollock, BG, Parepally, H, et al. (2000) Anticholinergic differences among patients receiving standard doses of olanzapine or clozapine. Journal of Clinical Psychopharmacology, 20: 311–6.
Chukhin, E, Takala, P, Hakko, H, et al. (2013) In a randomised placebo-controlled add-on study orlistat significantly reduced clozapine-induced constipation. International Clinical Psychopharmacology, 28: 68–70.
Cohen, D, Bogers, J, van Dijk, D, et al. (2012) Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. Journal of Clinical Psychiatry, 73: 1307–12.10.4088/JCP.11r06977
Cohen, D (2017) Clozapine and gastrointestinal hypomobility. CNS Drugs, 31: 1083–91.10.1007/s40263-017-0481-5
Crowell, MD (2001) The role of serotonin in the pathophysiology of irritable bowel syndrome. American Journal of Managed Care, 7: s252–60.
Damon, H, Dumas, P, Mion, F (2004) Impact of anal incontinence and chronic constipation on quality of life. Gastroenterologie Clinique et Biologique, 28: 16–20.
De Hert, M, Dockx, L, Bernagie, C, et al. (2011a) Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study. BMC Gastroenterology, 11 : 17.
De Hert, M, Hudyana, H, Dockx, L, et al. (2011b) Second-generation antipsychotics and constipation: a review of the literature. European Psychiatry, 26: 34–44.
De Hert, M, Correll, CU, Bobes, J, et al. (2011c) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10: 52–7.10.1002/j.2051-5545.2011.tb00014.x
Dennison, C, Prasad, M, Lloyd, A, et al. (2005) The health-related quality of life and economic burden of constipation. Pharmacoeconomics, 23: 461–76.
Drew, L, Herdson, P (1997) Clozapine and constipation: a serious issue. Australian and New Zealand Journal of Psychiatry, 31: 149–50.
Ducrotté, P, Milce, J, Soufflet, C, et al. (2017) Prevalence and clinical features of opioid-induced constipation in the general population: a French study of 15,000 individuals. United European Gastroenterology Journal, 5: 588–600.10.1177/2050640616659967
Dworkin, RH (1994) Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophrenia Bulletin, 20: 235–48.
Erickson, B, Morris, DM, Reeve, A (1995) Clozapine-associated postoperative ileus: case report and review of the literature. Archives of General Psychiatry, 52: 508–9.
Every-Palmer, S, Newton-Howes, G, Clarke, MJ (2014) Pharmacological treatment for antipsychotic-related constipation (protocol). Cochrane Database of Systematic Reviews, 5: CD011128.
Every-Palmer, S, Nowitz, M, Stanley, J, et al. (2016) Clozapine-treated patients have marked gastrointestinal hypomotility, the probable basis of life-threatening gastrointestinal complications: a cross sectional study. EBioMedicine, 5: 125–34.10.1016/j.ebiom.2016.02.020
Every-Palmer, S, Ellis, PM (2017a) Clozapine-induced gastrointestinal hypomotility: a 22-year bi-national pharmacovigilance study of serious or fatal ‘slow gut’ reactions, and comparison with international drug safety advice. CNS Drugs, 31: 699–709.
Every-Palmer, S, Ellis, PM, Nowitz, M, et al. (2017b) The Porirua protocol in the treatment of clozapine-induced gastrointestinal hypomotility and constipation: a pre- and post-treatment study. CNS Drugs, 31: 75–85.10.1007/s40263-016-0391-y
Fitzsimons, J, Berk, M, Lambert, T, et al. (2005) A review of clozapine safety. Expert Opinion on Drug Safety, 4: 731–44.10.1517/14740322.214.171.1241
Flanagan, RJ (2011) Gastrointestinal hypomobility: an under-recognised life-threatening adverse effect of clozapine. Forensic Science International, 206: e31–6.
Foxx-Orenstein, A, McNally, MA, Odunsi, ST (2008) Update on constipation - one treatment does not fit all. Cleveland Clinic Journal of Medicine, 75: 813–24.
Guarino, AH (2005) Treatment of intractable constipation with orlistat: a report of three cases. Pain Medicine, 6: 327–8.10.1111/j.1526-4637.2005.00053.x
Haddad, PM, Fleischhacker, WW, Peuskens, J, et al. (2014) SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): the development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects. Therapeutic Advances in Psychopharmacology, 4: 15–21.
Hayes, G, Gibler, B (1995) Clozapine-induced constipation. American Journal of Psychiatry, 152: 298.
Hibbard, KR, Propst, A, Frank, DE, et al. (2009) Fatalities associated with clozapine-related constipation and bowel obstruction: a literature review and two case reports. Psychosomatics, 50: 416–9.
Hynes, C, Keating, D, McWilliams, S, et al. (2015) Glasgow Antipsychotic Side-effect Scale for Clozapine: development and validation of a clozapine-specific side-effects scale. Schizophrenia Research, 168: 505–13.
Ikai, S, Suzuki, T, Uchida, H, et al. (2013) Reintroduction of clozapine after perforation of the large intestine: a case report and review of the literature. Annals of Pharmacotherapy, 47: e31.10.1345/aph.1S117
Ingimarsson, O, MacCabe, JH, Sigurdsson, E, et al. (2018) Constipation, ileus and medications use during clozapine treatment in patients with schizophrenia in Iceland. Nordic Journal of Psychiatry, 72: 497–500.
Karmacharya, R, et al. (2005) Clozapine-induced eosinophilic colitis. American Journal of Psychiatry, 162: 1386–7.
Khalili, B, Bardana, EJ Jr, Yunginger, JW (2003) Psylium associated anaphylaxis and death: a case report and review of the literature. Annals of Asthma, Allergy and Immunology, 91: 579–84.10.1016/S1081-1206(10)61538-4
Koch, A, Voderholzer, WA, Klauser, AG, et al. (1997) Symptoms in chronic constipation. Diseases of the Colon & Rectum, 40: 902–6.
Kune, GA (1993) Laxative use not a risk for colorectal cancer: data from the Melbourne Colorectal Cancer Study. Zeitschrift für Gastroenterologie, 31: 140–3.
Leng-Peschlow, E (1992) Senna and its rational use. Pharmacology, 44: S1–52.
Leong, QM, Wong, KS, Koh, DC (2007) Necrotising colitis related to clozapine? A rare but life threatening side-effect. World Journal of Emergency Surgery, 2: 21.
Levin, TT, et al. (2002) Death from clozapine-induced constipation: case report and literature review. Psychosomatics, 43: 71–3.
Lewis, SJ, Heaton, KW (1997) Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology, 32: 920–4.
McKinnon, ND, Azad, A, Waters, BM, et al. (2009) Clozapine-induced bowel infarction: a case report. Psychiatry, 6: 30–5.
Meltzer, HY, Nash, JF (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacological Reviews, 43: 587–604.
Meyer, JM, Cummings, MA (2014) Lubiprostone for the treatment-resistant constipation associated with clozapine use. Acta Psychiatrica Scandinavica, 130: 71–2.
Morales, MA, Hernández, D, Bustamante, S, et al. (2009) Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity? Journal of Toxicology, 2009: 287247.
Muller-Lissner, SA (1988) Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis. BMJ (Clinical Research Edition), 296: 615–7.
Muller-Lissner, S, Bassotti, G, Coffin, B, et al. (2017) Opioid-induced constipation and bowel dysfunction: a clinical guideline. Pain Medicine, 18: 1837–63.
National Prescribing Centre (2011) The management of constipation. Medical Record Bulletin, 21: 1–8.
Nielsen, J, Meyer, JM (2012) Risk factors for ileus in patients with schizophrenia. Schizophrenia Bulletin, 38: 592–8.
Nusko, G, Schneider, B, Schneider, I, et al. (2000) Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut, 46: 651–5.
Oke, V, Schmidt, F, Bhattarai, B, et al. (2015) Unrecognized clozapine-related constipation leading to into-abdominal sepsis - a case report. International Medical Case Reports Journal, 8: 189–92.
Palmer, SE, McLean, RM, Ellis, PM, et al. (2008) Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. Journal of Clinical Psychiatry, 69: 759–68.10.4088/JCP.v69n0509
Poetter, CE, Stewart, JT (2013) Treatment of clozapine-induced constipation with bethanechol. Journal of Clinical Psychopharmacology, 33: 713–4.10.1097/JCP.0b013e3182a1160d
Rondla, S, Crane, S (2007) A case of clozapine-induced paralytic ileus. Emergency Medicine Journal, 24: e12.
Schwartz, BJ, Frisolone, JA (1993) A case report of clozapine-induced gastric outlet obstruction. American Journal of Psychiatry, 150: 1563.
Shammi, CM, Remington, G (1997) Clozapine-induced necrotizing colitis. Journal of Clinical Psychopharmacology, 17: 230–2.10.1097/00004714-199706000-00021
Shirazi, A, Stubbs, B, Gomez, L, et al. (2016) Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis. International Journal of Molecular Sciences, 17: E863.
Stubbs, B, Thompson, T, Acaster, S, et al. (2015) Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies. Pain, 156: 2121–31.10.1097/j.pain.0000000000000304
Taylor, DM (2017) Clozapine for treatment-resistant schizophrenia: still the gold standard? CNS Drugs, 31: 177–80.
Taylor, DM, Barnes, TRE, Young, AH (2019) The Maudsley Prescribing Guidelines in Psychiatry (13th edn). Wiley.
Townsend, G, Curtis, D (2006) Case report: rapidly fatal bowel ischaemia on clozapine treatment. BMC Psychiatry, 6: 43.
Vaswani, SK, Hamilton, RG, Valentine, MD, et al. (1996) Psylium laxative-induced anaphylaxis, asthma, and rhinitis. European Journal of Clinical Immunology, 51: 266–8.
Wald, A, Scarpignato, C, Kamm, MA, et al. (2007) The burden of constipation on the quality of life: results of a multinational survey. Alimentary Pharmacology of Therapeutics, 26: 227–36.
Weinstein, M (2001) First do no harm. The dangers of mineral oil. Paediatric Child Health, 6: 129–31.
West, S, Rowbotham, D, Xiong, G, et al. (2017) Clozapine induced gastrointestinal hypomotility: a potentially life-threatening adverse event: a review of the literature. General Hospital Psychiatry, 46: 32–7.10.1016/j.genhosppsych.2017.02.004
Wilson, N, Schey, R (2015) Lubiprostone in constipation: clinical evidence and place in therapy. Therapeutic Advances in Chronic Disease, 6: 40–50.
Xing, JH, Softer, EE (2001) Adverse effects of laxatives. Diseases of the Colon and Rectum, 44: 1201–9.
Young, CR, Bowers, MB Jr, Mazure, CM (1998) Management of the adverse effects of clozapine. Schizophrenia Bulletin, 24: 381–90.10.1093/oxfordjournals.schbul.a033333
Yu, SC, Chen, HC, Lee, SM (2013) Rapid development of fatal bowel infarction within 1 week after clozapine treatment: a case report. General Hospital Psychiatry, 35: 679.10.1016/j.genhosppsych.2013.03.002